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Abstract  
A clinical prediction model (CPM) is a tool for predicting healthcare outcomes, usually within a 
specific population and context. A common approach is to develop a new CPM for each 
population and context, however, this wastes potentially useful historical information. A better 
approach is to update or incorporate the existing CPMs already developed for use in similar 
contexts or populations. In addition, CPMs commonly become miscalibrated over time, and 
need replacing or updating. In this paper we review a range of approaches for re-using and 
updating CPMs; these fall in three main categories: simple coefficient updating; combining 
multiple previous CPMs in a meta-model; and dynamic updating of models. We evaluated the 
performance (discrimination and calibration) of the different strategies using data on mortality 
following cardiac surgery in the UK: We found that no single strategy performed sufficiently 
well to be used to the exclusion of the others. In conclusion, useful tools exist for updating 
existing CPMs to a new population or context, and these should be implemented rather than 
developing a new CPM from scratch, using a breadth of complementary statistical methods. 
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1. Introduction 
Clinical prediction models (CPMs) are tools for predicting the natural course of diseases or the 
responses of patients to healthcare interventions, with regard to specific endpoints and 
observable characteristics1. For example, clinicians, healthcare managers and patients may be 
interested in assessing the risk of dying within 30 days of undergoing a heart bypass operation. 
We expect this risk to depend both on the characteristics of the patient, such as gender, age, 
and comorbidities, and on the characteristics of the intervention, such as the experience of the 
surgeon. A CPM is usually developed by fitting a statistical model to existing data. The choice 
of model to be fitted depends on the nature of the endpoint; common choices are logistic 
regression (for a binary endpoint) and survival models (for a time-to-event endpoint). 
CPMs have three main practical uses. First, they may be used at an individual patient level to 
communicate risk and aid in the clinical decision-making process by stratifying patients into 
different treatment option groups2 or to determine whether further testing is warranted to 
reach an appropriate decision3,4. Second, they may be used for planning healthcare services by 
predicting disease prevalence and future demand on services, or to explore the consequences 
of different local policy options. Third, they may be used in the quality management of 
healthcare services, where clinical audit processes compare observed with expected outcomes, 
given appropriate adjustments for differences in case-mix (e.g. ensuring the surgeon who takes 
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on difficult cases, with a higher baseline risk, is appropriately compared with his/her peers 
who operate on lower risk patients)5,6. 
The topic of developing, validating and using CPMs receives considerable attention in the 
statistical and clinical literature; for a recent overview see the PROGRESS paper series 2,7–9. The 
importance of transparent reporting of the development, monitoring and validation of CPMs 
has recently been emphasised by the TRIPOD statement10. 
In practice, CPMs are usually selected or developed for a given population and endpoint of 
interest. There are two general approaches: 1) develop a new CPM in the population of 
interest; or 2) use an existing CPM that has been developed and used in related contexts. The 
first approach wastes prior information, risks over-fitting, and ultimately leads to many CPMs 
existing for the same endpoint, which is confusing and makes it difficult to decide which one to 
apply in practice. The second approach may result in a CPM that is not fit for purpose, poorly 
calibrated and lacking discrimination. A better way forward may be to combine these 
approaches and work from the ‘middle ground’ in which existing CPMs that may be relevant 
for the population and endpoint of interest are taken, and revised to suit the new population. 
Another common pitfall with CPMs is that their performance can deteriorate over time: 
calibration drift11(P392). This can be attributed to changes over time in: prevailing disease risks 
(e.g. the obesity epidemic accelerating the force of diabetes morbidity); unmeasured risk 
factors for disease and treatment outcomes; treatments; treatment settings; adjunct 
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treatments and wider healthcare; and data quality. Therefore, to remain valid, CPMs must 
evolve over time – either by renewing or updating the model at discrete timepoints12, or by 
allowing the CPM to operate dynamically, updating continuously in an online fashion13. 
The quantitative performance of a CPM can be evaluated through its discrimination (how well 
patients with poor outcomes are separated from those with better outcomes) and calibration 
(agreement between probabilities from the CPM and observed outcome proportions). These 
can be assessed internally (using, for example, cross-validation to correct for within-sample 
optimism) or, more preferably, externally using a different population14. The discrimination is 
measured by the area under the receiver operating characteristic (ROC) curve (AUC)15, with a 
larger AUC indicating a better prediction model. The ROC is a plot of the sensitivity versus 1-
specificity for a CPM, based on dichotomizing the predicted probabilities from this CPM into 
disease and non-disease two groups over a continuous range of thresholds. Approaches exist 
to construct a 95% confidence interval (CI) for the AUC16–19. A calibration plot20 plots the 
observed against the predicted outcome probabilities. For a perfectly calibrated model, this 
should fall on a 45 degree straight line. A univariate logistic regression model can also be used 
to assess calibration: a calibration intercept can be obtained by regressing the binary outcome 
on the predicted log-odds while fixing this log-odds as an offset variable ; and a calibration 
slope can be obtained by a separate fit while fixing the intercept at previously estimated 
value21. A method with good calibration should have zero intercept and a slope of one. If the 
intercept is greater (smaller) than zero, it indicates the prediction is systematically too small 
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(too large); if slope is bigger (smaller) than one, it indicates CPM is under-fitting (over-fitting) 
the data. Other measures to assess the performance of CPMs can be found in Steyerberg et 
al.4 or Austin et al22. A model with poor calibration can be recalibrated easily, whereas poor 
discrimination is far more difficult to improve.  
The aim of this paper is to highlight and compare various statistical strategies for modifying 
existing CPMs to perform well in a new population, and strategies to maintain performance 
over time. In Section 2 we review various statistical strategies for updating existing CPMs, 
focussing on developments since 2004, but with historical references where appropriate. We 
illustrate the application of these strategies using data from the UK and Ireland National Adult 
Cardiac Surgery Audit (NACSA) registry cardiac surgery data, which is introduced in Section 3. 
The performance of the selected strategies as applied to the NACSA data are presented in 
Section 4. We conclude in Section 5 with a discussion. 
2. Methods for updating CPMs 
Focussing on the statistical literature of the last 12 years (2004-2015), we have identified three 
main approaches for updating CPMs in light of new data. The first approach, which we term 
regression coefficients updating, focuses on updating some or all coefficients from an existing 
CPM. The second approach is meta-model updating, which synchronizes multiple existing 
CPMs into one new meta-CPM. The third approach is dynamic updating, in which one or 
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multiple CPMs can be continuously and simultaneously updated in calendar time, constantly 
learning from new data.  
Throughout this section we consider a situation in which we have 𝑀 previous logistic 
regression models available to predict a binary outcome 𝑌. These 𝑀 models have been 
developed in previous data. For model 𝑚, let 𝑋𝑚 denoting the design matrix of the covariates; 
𝛼𝑚 and 𝛽𝑚 be the original model intercept and a vector of slopes respectively, and 𝐿𝑃 stands 
for linear predictors, so the model is specified by: 
logit(𝑃[𝑌 = 1]) =  𝛼𝑚 + 𝛽𝑚𝑋𝑚 = 𝛼𝑚 + 𝐿𝑃𝑚, 
and 𝑚 = 1, … , 𝑀. We wish to update, potentially combine, and apply these models in new 
data, termed the updating dataset. 
2.1 Regression coefficients updating 
A simple and widely used strategy is to update the regression coefficients of an existing CPM. 
This approach can be broadly placed into six ordinal categories based on the extent of 
modification4,12: 1) update the intercept only; 2) update the intercept and adjust the other 
regression coefficients by a common factor; 3) category 2 plus extra adjustment of a subset of 
the existing coefficients to a different strength; 4) category 3 plus adding new predictors; 5) re-
estimate all of the original regression coefficients; 6) category 5 plus adding new additional 
predictors. These approaches have been used in various medical applications23–25 26,27 and were 
applied to single CPM update. 
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The first two categories influence the calibration performance of the CPM but not the 
discrimination. They assume that the relative association between predictors and outcome 
stays at the same level between the original and new datasets, and the only difference 
between the two datasets is the observed outcome frequencies. Calibrating the intercept 
ensures that the observed and expected outcome rate agree on the new dataset. For a given 
model 𝑚  this strategy recalculates a new intercept, 𝛼𝑚
𝑈1, via fitting a new logistic regression 
model using the updating dataset while taking the LPm from the original model as an offset, 
that is to fix the coefficient for LPm at unity:  
logit(𝑃[𝑌 = 1]) =  𝛼𝑚
𝑈1 + 𝐿𝑃𝑚. 
The coefficients for the predictors therefore stay unchanged at 𝛽𝑚 for the updated model. 
Such a method has been proposed in predicting the risk of severe postoperative pain28.  
Method 2 is referred to as “logistic calibration”29, and estimates an overall correction factor 
and proportionally adjusts the original coefficients by this factor. It works by fitting a univariate 
logistic regression using 𝐿𝑃𝑚 from the original model 𝑚 as the covariate. The new predictor-
outcome associations are then 𝛽𝑚
𝑈2 = 𝐵𝑚𝛽𝑚 with a new intercept to be 𝛼𝑚
𝑈2 = 𝐴𝑚: 
logit(𝑃[𝑌 = 1]) =  𝐴𝑚 + 𝐵𝑚𝐿𝑃𝑚. 
These first two strategies are the simplest and can work effectively when the size of the new 
dataset is relatively small and the case-mix is similar in the updating and validation sets. 
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The remaining approaches should be considered if discrimination is of concern, the strength of 
the association between some predictors and the outcome is thought to be substantially 
different in the new population, or it may be useful to consider some predictors that were not 
in the original CPM. Method 3 updates a CPM using method 2 first, then re-estimates a subset 
of the coefficients that exhibit different strength in the original and new datasets. Some 
authors23–25 used objective criteria such as the likelihood ratio test and forward stepwise 
variable selection to decide which coefficients needed to be adjusted; while others28,30 used 
expert knowledge for this decision. Method 4 involves extending the original model by 
including new risk factors which were not originally in a CPM30. These newly added predictors 
may not have been available when a CPM was first developed, and could lead to further 
improvement in both calibration and discrimination. 
When methods 1 to 4 appear to be inadequate, more extensive revisions can be considered. In 
Methods 5 and 6, the only way in which the original CPM is used is to select the covariates for 
inclusion in the model. The historical data is otherwise disregarded. Specifically, Method 5 fits 
a new CPM based exclusively on the covariates from the existing CPM, i.e. fitting: 
logit(𝑃[𝑌 = 1]) =  𝛼𝑚
𝑈3 +  𝛽𝑚
𝑈3𝑋. 
Method 6 additionally allows new predictors to be added. If the original individual-level data 
are available, these can be combined with the updating dataset to build a new model12. Both 
Methods 5 and 6 are aggressive modelling approaches which give a low or no weighting to the 
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historical information, are likely to over-fit the data, and the resulting CPMs are less stable. 
The updated model may fit the local setting perfectly, but may lack external validity. 
To overcome the potential problem of over-fitting, applying shrinkage to CPMs estimated by 
Methods 3 to 6 has been proposed23, in which the updated coefficients are shrunk either 
towards zeros or towards the re-calibrated coefficients of Method 2. 
2.2 Meta model updating 
In the situation where there are multiple historical CPMs available in the literature for the 
same or similar endpoints and populations (e.g. there are a number of scores31–33 used for 
assessing the operative mortality after cardiac surgery in adults), meta-analysis techniques 
have been proposed to synchronize them into one meta-model, in the presence of an updating 
dataset34–36. Commonly, the original CPMs were derived independently from different 
populations. The individual-level data used to fit the original CPMs are unlikely to be available, 
and each of these CPMs may have a distinct set of predictors. By combining these CPMs 
together, the resulting meta-CPM may have better performance than each individual CPM and 
be more amenable to generalization to a wider population. 
We use the notation above to accompany the main text to explain how a meta model can be 
created in practice.  Assume there are M historical CPMs, each with their own design matrix 
X1, …XM. The (co)variance among these model coefficients (𝛼1, 𝛽1), … , (𝛼𝑀 , 𝛽𝑀)
 could be 
obtained; but the original individual-level data may not always be available.  A new dataset 
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with individual-level data Z=(Y’,X’) are available for updating. A meta-model aims to summarize 
all the information from M historical models and the new data Z into an overall effect model 
CPMT : logit(𝑃[𝑌 = 1]) = 𝛼𝑇 + 𝛽𝑇𝑋. 
A two-stage strategy has been proposed under the scenario when all the historical CPMs and 
the updating dataset have the same set of predictors34.  In the first stage, the new dataset Z is 
summarized into estimates of association between outcome and predictors (i.e. to estimate 
logit(𝑃[𝑌 = 1]) = 𝛼𝑍 + 𝛽𝑍𝑋 using data Z). This step can be carried out by any method as if a 
new CPM is first built using the updating dataset. As a result, the new individual data are 
reduced into model coefficients 𝛼𝑍 and 𝛽𝑍, and their covariance estimates. In the second stage, 
traditional meta-analysis techniques are applied to combine the coefficients of (𝛼1, … , 𝛼𝑀 , 𝛼𝑍)  
and (𝛽1, … , 𝛽𝑀 , 𝛽𝑍) from the new and the historical models together into 𝛼𝑇 and 𝛽𝑇. These 
meta-analysis techniques include: 1) a naïve univariate meta-analysis, which pools estimated 
effects among various studies via weighted least squares; 2) multivariate meta-analyses with a 
random effects model considering both within and between studies correlations; and 3) 
Bayesian inference that use the historical data CPM1 … ,CPMM to construct a prior, and use the 
individual data from updating set Z as likelihood; then a new meta-CPMT  is formed from the 
posterior distribution. The intercept of the meta-model is then recalibrated as per the 
approaches described in Section 2.1. These methods were applied, for example, on a traumatic 
brain injury and deep venous thrombosis data and it was concluded that the meta-CPM 
approach improved the discrimination and calibration compared with refitting a new model 
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using only the updating dataset (ignoring any historical information)34. The first two meta-
analysis techniques value the historical and the updating datasets equally and produce 
averaged pooled coefficient effects, therefore it may not predict the target population well as 
a result. It emphasizes the target updating population more than the historical data. All these 
strategies assume CPMs share a similar set of predictors, which is not always realistic. 
Although various remedies had been proposed regarding how to impute the between-risk-
factors covariance when they are not available, the robustness of these imputation methods is 
unknown. It is not clear how to update predictors in the sense of adding or removing 
predictors under these frameworks. 
Debray et al.35 provide methods for the case where all individual-level data from all the original 
historical models are available. Their approaches involve re-fitting a meta-model using all the 
historical individual data, while allowing study-specific intercepts to account for different 
sources of historical data. That is to create one CPM: logit(𝑃[𝑌 = 1]) = 𝛼𝑖
𝑈 +  𝛽𝑈𝑋  for all 
source of dataset i=1.…M  with a commonly shared predictor-outcome association 𝛽𝑈 for all i. 
This is achieved using a random intercept model, or stratified estimation of the study-specific 
intercept 𝛼𝑖
𝑈, to account for the heterogeneity caused by different baseline risk from different 
populations. Various proposals are then made to choose the intercept to use for the new study 
population. However, this approach only allows the intercept to vary between populations; 
hence, if the predictor-outcome relationships are highly heterogeneous, the meta-CPM will 
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perform poorly. As a result, although more information is available, these methods35 could still 
be out-performed by a traditional meta-analysis34 method. 
The above updating schemes are limited to the case when all sources of data share the same 
set of predictors. Model averaging and stacked regression do not have such a constraint36 (i.e. 
variables for X1 ,…,XM, X’ can be all or partially the same, or completely distinct). There are 
three steps involved in a model averaging meta-model update. The first step involves updating 
each of the historical CPM via the approaches discussed in Section 2.1. The second step applies 
Bayesian model averaging on all historical CPMs and obtains weighted average predictions for 
each individual.  The weights are calculated as 𝑤𝑚 = exp(−0.5𝐵𝐼𝐶𝑚)/ ∑ exp(−0.5𝐵𝐼𝐶𝑚)𝑚 ; 
where 𝐵𝐼𝐶𝑚 =  −2𝑙𝑚 + 𝑘𝑚 log(𝑁), 𝑙𝑚 is the log-likelihood, 𝑘𝑚 is the number of parameters 
been updated in the first step (e.g. one parameter for the intercept update), and 𝑁 is total 
number of patients in the updating dataset. The third step refits a meta-model using weighted 
average predictions from the contributing scores as the dependent variable, and using all 
variables from the original models as independent variables. This approach gives more weight 
to CPMs which fit the updating dataset better (with higher likelihood) and to those with a less 
complicated update (penalising those with fewer parameters changed less heavily) in step 1. 
However, it is not clear how intensive the update should be in step 1; with different strategies, 
the weights assigned to different historical CPMs would be different and the final meta-model 
would thus be affected. This model averaging strategy has a tendency to become model 
selection, assigning a weight of 1 to a single CPM and a weight of 0 to the remaining ones: 
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because the weight is assigned by an exponential function, a small differences in likelihood or 
penalizing term could easily inflate a model weight to unity or null.   
The stacked regressions meta-model proposal uses the risk score from each CPM as a predictor 
in a new meta-CPM, which is therefore a logit-linear combination of all pre-existing CPMs36. It 
calculates a weight 𝜋𝑚 for each model m and updates the coefficients in one go, with the new 
coefficients for each individual model hence being 𝛽𝑚
𝑈6 = 𝛽𝑚𝜋𝑚, but overall coefficients being 
𝛽𝑈6 =  ∑ 𝛽𝑚𝜋𝑚𝑚 . The form of the meta-model using stacked regression is: 
logit(𝑃[𝑌 = 1]) =  𝜋0 +  ∑ 𝜋𝑚𝐿𝑃𝑚𝑚 .  
This strategy uses the updating data less intensively with fewer parameters to be estimated 
comparing with the model averaging proposal. However, there are clearly multicollinearity 
issues in the meta-CPM model, and the quoted papers failed to demonstrate whether the 
stacked regression approach outperformed alternatives using simulation. 
In summary, meta-models combine several CPMs into one updated CPM, and have the 
potential to generalize to a wider population, and to have better performance than the 
individual CPMs. However, fitting a meta-model may not be practical when there is only a 
small number of historical CPMs (random effects cannot be estimated, and the weights 
calculated are unstable). The usual good practice of conducting a meta-analysis, such as 
selecting well-designed historical CPMs to be combined, should be applied. None of the meta-
analysis strategies have discussed adding new predictors. All the meta-model update 
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techniques described in this section are relatively new applications to the CPM literature. 
More research is needed to establish principles such as how frequently an update should be 
carried out, how big the updating dataset should be, and how to conduct model selection. 
2.3. Dynamic model (DM) updating 
Dynamic updating refers to the continuous updating of one13 or multiple37,38 CPMs , as 
opposed to the previous approaches that are only conducted at fixed time points. As a result, 
the coefficients for an updated CPM are continuously varying with time. In this section we 
focus on a Bayesian dynamic logistic regression for a single CPM update (“DM”). For a single 
model 𝑚, let 𝜃𝑚
𝑡 = (𝛼𝑚
𝑡 , 𝛽𝑚
𝑡 )′ be the vector of parameters for model 𝑚 at time 𝑡. Let 𝑌𝑡 and 
𝑋𝑡 denote the outcome data and covariate data available up to time 𝑡, and 𝑦𝑡 and 𝑥𝑡 the data 
from time 𝑡 only. Let 𝜆 be a forgetting parameter. The procedures can be initiated by assuming 
𝜃𝑚
0 is normally distributed with mean estimated at the historical model coefficients (i.e. 
𝜃𝑚
0 = (𝛼𝑚, 𝛽𝑚)′), and covariance matrix Σ
0
estimated (for example) using one-tenth of the 
updating data (if it is not available from the historical model). Then the prediction equation is:  
𝑝(𝜃𝑚
𝑡 |𝑌𝑡−1, 𝑋𝑡−1) =  𝑁(𝜃𝑚
𝑡−1, 𝑅𝑡);      𝑅𝑡 =  𝜆−1Σ𝑡−1. 
The updating equation is proportional to the product of a Bernoulli density (Likelihood) and 
the prediction equation (Prior) so that the whole procedure has a Bayesian interpretation:  
𝑝(𝜃𝑚
𝑡 |𝑌𝑡 , 𝑋𝑡) ∝ 𝑝(𝑦𝑡|𝜃𝑚
𝑡 )𝑝(𝜃𝑚
𝑡 |𝑌𝑡−1, 𝑋𝑡−1) ∝ Likelihood × Prior 
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The estimate of 𝜃𝑚
𝑡  is chosen to maximise this expression; the expression cannot be written in 
closed form, so is approximated using a Normal distribution.  
The forgetting parameter  is embedded in the prediction equation which controls the 
variance of the prior distribution in the updating equation: with a small  it is equivalent to 
have a less informative prior that the updated model will rely less on the historical information 
(through a flatter prediction equation).  
The estimating procedure involves recursively applying the prediction and the updating steps.  
The DM updating can also be applied to several CPMs simultaneously, resulting in dynamic 
model averaging (DMA)37,38. This assumes that there are multiple historical CPMs acting 
together at all times; at a given time, some are more predictive than others, and how well a 
CPM predicts may alter over time. A physical example might refer to the existence of several 
latent sub-populations, and the proportions of these sub-populations in a target population 
may vary over time. Each of these sub-populations can be predicted by a specific CPM model. 
Therefore, DMA can be used to predict an optimal weighted average for the whole population 
at any time point. 
DMA has been applied to a continuous outcome in an engineering cold rolling mill example37 
and to a binary outcome medical example of paediatric laparoscopic appendectomies38. In the 
latter medical example, the purpose of the study was for inference rather than future 
prediction, and we are not aware of any DMA application on updating CPMs. However, a single 
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DM update has been applied in cardiac surgery data10. In general, DM can continuously adapt 
to the changes of the underlying process, without paying a high price for model uncertainty in 
a big model space, and is relatively insensitive to the choice of forgetting parameters except 
when responding to abrupt changes37. The forgetting parameters can be selected using an 
auto-tuning procedure. Although this procedure can be conducted at each time point, for each 
parameter, and on a continuous scale, this has a high computational load. Therefore, a 
simplified discrete proposal on the choice of forgetting parameters has been suggested for 
computational feasibility38. DM incorporates historical data, which is likely to provide a smooth 
and stable update to the coefficients13. Most of the applications so far are explanatory in 
nature to study the relationship between outcome and predictors, less so for the prediction 
purpose. 
Comparing DMA with meta-CPM using Bayesian model averaging (BMA) approach36, the latter 
case considered a fixed set of ‘true’ models while the former method allowed the multiple 
‘true’ models to vary over time. If any static strategy were applied repeatedly over time, this 
would itself become a dynamic approach39,40.  
To summarize, DMs are more adaptive than the single static model solutions described in 
Sections 3.1 and 3.2. Although a static model can be updated repeatedly, these methods 
would only be implemented when there are fair amounts of new data available, and 
consequently they should not be conducted too often. The risk factors of a CPM are likely to 
evolve slowly over time; DM responds to this in a smooth way. DMA has the ability to consider 
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a huge model space, in that case it might be viewed as an automatic model selection process 
by implementing this approach on all 2k possible models (with k covariates), and one can 
identify the most active models using posterior model probabilities. However the computing 
load might not be trivial. Moreover, it is not clear how a dynamic model should be validated, 
and there may be issues with clinical acceptability if outputs, and hence recommended clinical 
decisions may be changing from one day to the next. 
We are now turning towards evaluating the different proposals. To do so, we will use data 
from the National Adult Cardiac Surgery Audit (NACSA) registry, which is described in more 
detail in the next section. 
 
3. National Adult Cardiac Surgery Audit (NACSA) Registry Data 
Members of the Society for Cardiothoracic Surgery in Great Britain and Ireland (SCTS) submit 
clinical data on adult cardiac surgery operations to the National Adult Cardiac Surgery Audit 
(NACSA) registry—one of six national clinical audit databases managed by the National 
Institute of Cardiovascular Outcomes Research (University College London), covering all 
National Health Service trusts and some private and Irish hospitals. The SCTS have been 
recording data in some form since 1977, and have published risk-adjusted mortality outcomes 
on the individual surgeon level since 200511. 
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Historically, the commonly used risk score for auditing and decision-making in cardiac surgery 
in the UK was the logistic EuroSCORE41 (ES), which was published to replace the additive 
EuroSCORE risk score42. This is a logistic regression model that produces a predicted probability 
of mortality for patients due to any cause following a cardiac operation, based on risk factors 
available before a procedure is carried out. ES is based on data collected in 1995 (although the 
logistic model was not published until 2003), and over time it has become poorly calibrated43. 
More recently this has been replaced with EuroSCORE II44,45 (ES2), which is based on data 
collected in 2010. Whilst structurally similar to ES, ES2 updates the definition of some original 
risk factors. For example, ES did not differentiate risk between a patient having an isolated 
mitral valve repair operation and a patient have quadruple coronary artery bypass surgery, 
mitral valve repair and aortic valve replacement, whereas ES2 introduces a ‘weight of 
intervention’ variable. Furthermore, ES2 incorporates some new factors, and removes others. 
The complete NACSA registry was downloaded and pre-processed using cleaning rules 
developed in collaboration with cardiac surgeons46. These rules were employed to harmonise 
transcriptional discrepancies, map data between different database versions, remove clinically 
implausible values, and remove paediatric, duplicate and non-cardiac surgery records. 
Following this all records between 1st April 2007 and 31st March 2012 were retained. Figure 1 is 
a flow chart showing various subsets of NACSA data. There are 182,492 records during this five 
year period. As the focus of this paper is illustration of methodology rather than clinical use, 
we restricted our subjects to those who received coronary artery bypass graft surgery (CABG) 
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either isolated or with other concomitant cardiothoracic surgery. However, we note that the 
EuroSCORE models were developed for prediction in the population of all cardiac surgery 
patients, not a specific procedural subgroup. We conducted our analyses on a single imputed 
dataset derived using the chained equations technique47,48.  There were 127,946 patients after 
imputation.  Complete-case analysis was also carried out as a sensitivity analysis  (114,345 
complete cases) and results for this are reported in the Supplemental Material. Construction of 
the datasets is reported in Figure 1 and Table 1.  
The NACSA dataset was chronologically ordered according to the date of surgery, then split in 
a 2:1 ratio with the first two-thirds of the data (n=85,297) used for updating; and the 
remaining third (N= 42,649) used for validation. As the two datasets are from difference time 
periods, this constitutes transportability rather than internal validation49. 
 
4. Analysis and Results 
4.1 Comparative evaluation setup 
In order to demonstrate some of the methodologies described in Section 2 and highlight 
differences between them, we chose ES41 and ES244 to be updated using the NACSA updating 
dataset. Once the update was considered to be satisfactory, the updated models were tested 
on the NACSA validation dataset. 
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There is evidence that both ES and ES2 are miscalibrated on contemporary NACSA data, due to 
differences in characteristics between NACSA and the original datasets on which the two 
scores were derived43,45. Moreover, the predicted (risk-adjusted) mortality has increased over 
time in the dataset from 6.09% and 2.93% (2007/08) to 6.51% and 3.26% (2011/12) for ES and 
ES2 respectively. 
The crude mortality in the updating dataset is 2.67% in contrast to 4.8% and 3.9% for the data 
on which ES and ES2 are based on respectively. Applying both scores directly to the updating 
dataset, they showed good discrimination (AUC for ES: 0.817 (95% CI: 0.809, 0.826); for ES2: 
0.831 (95% CI: 0.823, 0.839 )), but over-predicted the mean mortality to be 6.16% using ES and 
2.94% using ES2. The miscalibration of ES is also reflected in a logistic regression of the 
outcome on the predicted log-odds yielding slopes (0.97 (SE=0.009)) and intercepts (-0.99 
(SE=0.022)) different from 1 and 0 respectively. These results highlight the need for exploring 
revised models for use in the NACSA data. 
Table 1 Imputed data analysis: Summary of the original, updating, and validation 
datasets . 
 ES original data ES2 original 
data 
NACSA 
updating 
NACSA 
validation  
Data 
collection 
period 
Sep-Nov 1995 3rd May-25th Jul 
2010 
1st April 2007-
26th May 2010 
26th May 2010- 
31st Mar 2012 
Sample size 19,030 22,381 85,297 42,649 
Setting 128 surgical 154 hospitals, 43 hospitals, 1  43 hospitals, 1 
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centres, 8 
countries* 
43 countries* country(UK) country(UK) 
 
Mortality % 4.8% 3.9% 2.67% 2.69% 
*Data from UK were included in both ES and ES2. 
 
 
In the remainder of this section we illustrate six of the updating strategies:  
 Strategy I: Intercept update (Category 1 in Section 2.1).  
 Strategy II: Logistic calibration (Category 2 in Section 2.1).  
 Strategy III: Model refit (Category 5 in Section 2.1).  
 Strategy IV: Dynamic updating using Bayesian dynamic logistic model for 
single CPM (DM). For the current analysis  is treated as a time-invariant 
scalar, fixed at 0.99 for the main analysis with sensitivity analysis conducted 
for other values of (see Section 4.3). Updates were made on a monthly basis. 
We use the updated CPM on 5th May 2010 (the final date of the updating data) 
for validation purposes. 
 Strategy V Meta-model with model averaging update. For this analysis, 
almost all the weight was placed on ES2 hence this strategy resembles a model 
selection procedure (the weight for ES is 5.2 × 10−71). We therefore also 
evaluated a pragmatic approach of assigning equal weights to both CPMs. 
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Most of the ES2 predictors are not new to ES but change their definitions from 
ES, while 9 predictors share exactly the same definitions in ES and ES2. For 
those re-defined variables, we adopt their newer definitions.  
 Strategy VI: Meta-model with stack regression update. For the initial 
recalibration stage, we used intercept updating only. 
All analyses were conducted using R50 (version 3.0.1). R Packages pROC51 and dma52 were used 
to calculate AUC and for DM modelling respectively. The (Cox) calibration21 intercept and slope 
were estimated using univariate logistic regression.  Calibration plots22 were produced using 
lowess smoother.  R codes are available on request from the authors.  
4.2 Validation results  
Table 2 summarises the calibration and discrimination performance of an updated CPM using 
the validation dataset based on the six selected strategies.  
When the original ES was applied directly to the validation dataset, it showed good 
discrimination (AUC=0.819) but it systematically over-estimated the mortality (calibration 
intercept=-1.06, slope=0.97). All updating strategies greatly improved the calibration over the 
original model and slightly improved discrimination. Adjusting the model intercept (Strategy I) 
contributed the most toward calibration improvement with the calibration intercept changing 
from -1.06 to -0.07. All Strategies II to IV showed further improvement of calibration and 
23 
 
discrimination over Strategy I which suggested the strength of predictors and outcomes 
association is different in the original ES and the NACSA datasets. 
The unmodified ES2 showed good discrimination (AUC=0.828) but slightly overestimated the 
mortality (calibration intercept of -0.20) in the validation dataset. With simple intercept 
adjustment (Strategy I) the updated CPM showed good fit to the validation data, with the 
calibration slope and intercept becoming very closed to1 and 0 respectively(although 
calibration intercept is still statistically significantly different from zero). Here, the updated 
models using Strategies II to IV made little or no improvement to model performance, 
compared with Strategy I. 
The meta-model Strategy V using pragmatic equal weights approach performed better than 
each of the individual original CPMs, mainly as a result of both intercepts of the original CPMs 
being updated before the two models were combined. With one extra predictor than the 
original ES2, this meta-model had better calibration than the original ES2. Strategy VI of 
stacked regression modelling performed better than ES and ES2 although this improvement is 
slight; as expected it assigned more weight to ES2 (𝜋1 = 0.90) than ES (𝜋2 = 0.18), but the 
difference is far less extreme than strategy V.  
As an alternative to Cox recalibration, the calibration plots of the binary observed outcomes 
regressed on the predicted probabilities from an updated CPM using non-parametric loess 
smoother  were also examined (Figure 2).  The results showed similar patterns to the results 
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reported above, that not a single method out-performed others. The lack of calibration was 
mainly demonstrated in the high predicted probabilities range.  
The complete-case analysis is reported in Supplemental Material.  For all 6 updating strategies 
chosen, they showed similar discrimination and calibration to the imputed-data analyses.  
Table 2. Imputed data analysis: Performance of updated CPMs on the validation dataset.  
 Discrimination  Cox recalibration  
Strategy AUC (95% CI)  Intercept (SE) Slope (SE) 
     
Original EURO1 
(ES) 
0.8194 (0.8079-0.8309) 
 
 -1.06092 (0.031678)* 0.97285 (0.013164)* 
I 0.8194 (0.8079-0.8309)  -0.06656 (.031679)* 0.98535 (0.009733) 
II 0.8194 (0.8079-0.8309)  -0.05877(0.031291) 1.00109 (0.009745) 
III 0.8293(0.818-0.8405)  -0.03461(0.031345) 1.00293 (0.009856) 
IV ( =0.99) 0.8293(0.8181-0.8405)  -0.05159(0.031299) 1.00534 (0.009892) 
     
Original EURO2 
(ES2) 
0.8279(0.8164-0.8394) 
 
 -0.20358(0.031269)* 1.00855 (0.010277) 
 
I 0.8279(0.8164-0.8394)  -0.09525(0.031269)* 1.00803 (0.009952) 
II 0.8279(0.8164-0.8394)  -0.10722 (0.031611)* 0.99432 (0.009964) 
III 0.8344(0.8231-0.8457)  -0.10882(0.031611)* 0.99588 (0.010181) 
IV(=0.99) 0.8345(0.8232-0.8458)  -0.10719(0.031557)* 0.99874 (0.010170) 
     
Meta-model     
V 0.8289(0.8176-0.8402)  -0.09071(0.031405)* 1.00267(0.009944) 
VI 0.8297(0.8183-0.841)  -0.09920(0.031595)* 0.99588(0.009962) 
Values of intercept and slope in bold are significantly different from 0 or 1 respectively, 
using a p-value cutoff of 0.05. 
 
4.3 Sensitivity analysis on DM parameter 
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Sensitivity analysis was conducted on the forgetting parameter for a range of values 
between 0.5 and 1. For both ES and ES2, the best AUC and calibration were achieved when 
was close to 0.99. Despite 𝜆 being close to 1, there is still a significant amount of forgetting, 
because the forgetting operates in a compound manner, and there are 38 time points in the 
training dataset. A smaller forgetting parameter is equivalent to using a less informative prior 
in the updating equation stage, so that the data from the far past become less influential on 
the current dynamic model estimates. Using a smaller  the estimation relies on a smaller 
recent dataset, which made the validation results worse than with a larger 
We did not adopt dynamic model averaging here, but a single CPM dynamic model approach. 
We could input both ES and ES2 into a single DMA framework as two potential models and 
allow them to be active at different time and with different rates. However, due to the similar 
nature of these two models, they do not capture different dimensions to predict the mortality.  
5. Discussion 
In this paper we have reviewed a variety of approaches that can revise CPMs for a new 
population and maintain performance over time, and we have contrasted some of the key 
methods using a typical example of mortality surveillance around cardiac surgery. 
In the cardiac surgery example there was general agreement that an older risk score (logistic 
EuroScore; ES) needed to be updated while this was less evident for a more recent score 
(EuroScore II; ES2). Following Hickey et al13, the need for updating of ES is likely to be 
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attributed to a change in case-mix and various characteristics in the data that have changed 
over the years. In particular, the case-mix adjusted mortality rate had decreased substantially. 
In comparing the various updating approaches, we did not find any single method that 
outperformed the others, the differences are more nuanced. For situations where only small 
changes between the original and updating datasets occur, simple re-calibration methods, 
such as intercept updates, are sufficient as seen on the example of ES2. More involved 
methods are useful when larger changes are evident, as seen in the case of ES. It is also 
noteworthy here that we used a large updating dataset, which will support more complex 
updating strategies. Meta-model approaches are a new area and more research is needed 
before these approaches can be recommended, particularly around dealing with the high 
multicollinearity between the risk scores. Dynamic modelling is a promising area allowing 
continuous updating, which is particularly relevant given the trend towards instant data 
capture and regular uploads to a central database. One distinguishing feature of the various 
approaches is the quantity of information on previous data and models that are required to 
utilize a given approach, and how this past information is integrated into the new model. 
The validation we have provided is officially testing transportability rather than internal 
validation. However, the similarity of the time periods means this could be viewed as a split-
sample validation. From this perspective, such a method is known to be outperformed by 
bootstrapping base validation53. However, at the level of 38.3 events per variable in validation 
set (and 75.8 in updating set) the validation performance of these two methods are similar 53. 
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Other than the aforementioned methods, there are some pragmatic updating strategies which 
make ad-hoc adjustments to the predicted risks. For example, a calibration factor is published 
every quarter for The Society of Thoracic Surgeons National Adult Cardiac Surgery risk54. In 
order to consider clustering effects, at e.g. hospital level, methods such as random effects 
models or generalized estimating equations (GEEs) have been suggested31. However, such 
models may be difficult for clinical users to understand. 
Sophisticated updating based on a very small dataset should be applied with caution, because 
the methods discussed here put comparatively large weight on the updating data and hence 
the CPM would be prone to peculiarities of the updating dataset, and hence over-fitting. One 
potential remedy for this issue is to shrink the coefficient estimates towards the original CPM 
according to the relative sizes of the original and updating datasets. 
Although more complex approaches, such as DM or DMA, are attractive from a statistical 
standpoint, it is unclear how practical such approaches are. They will be more difficult to 
explain to non-statisticians, more difficult to validate, and implementation requires a 
continuous data stream. 
In conclusion, there are a wide range of updating methods available for applying CPMs in new 
populations and maintaining their performance over time – ranging from very simple 
calibration adjustments, to more involved approaches involving dynamic modelling or 
combining multiple CPMs. Whenever there are existing CPMs that have the potential to apply 
to the clinical domain or population of interest, their performance, and potential for updating 
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or revision, should be explored before considering the development of a new CPM from 
scratch. This will help to avoid the perplexing quantity of CPMs operating in similar or identical 
contexts. Although this article only focus on statistical aspect, a CPM should not only be judged 
by its quantitative performance; equally important is its clinical and face validity. 
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Figure 1: A flow chart of NACSA registry data structure. CABG=1 identified patients who 
underwent coronary artery bypass graft surgery. 
  
NACSA since 2007 
(N=182492) 
Complete cases 
for EuroSCORE I 
(N=116446) 
Complete cases 
for EuroSCORE II 
(N=115440) 
Complete data 
(N=114345) 
Updating 
Set(N=76230) 
Validation 
Set(N=38115) 
Imputed set 
(N=127946) 
Updating 
Set(N=85297) 
Valildation Set 
(N=42649) 
Complete 
outcomes 
(N=127913) 
CABG=1 
(N=127946) 
30 
 
ES Strategy I   Strategy II   StrategyIII 
 
ES2  Strategy I   Strategy II   Strategy III 
 
ES Strategy IV  ES2 Strategy IV 
  
Strategy V   Strategy VI 
  Figure 2: Calibration plot: Diagonal line 
has intercept=0 and slope=1. The binary outcomes were displayed as dots along y=0/1 lines. 
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Supplemental Material: Complete-case analysis  
Table S1.  Summary of the original, updating, and validation datasets. 
 ES original data ES2 original 
data 
NACSA 
updating 
NACSA 
validation  
Data 
collection 
period 
Sep-Nov 1995 3rd May-25th Jul 
2010 
1st April 2007-
5th May 2010 
5th May 2010- 
31st Mar 2012 
Sample size 19,030 22,381 76,230 38,115 
Setting 128 surgical 
centres, 8 
countries* 
154 hospitals, 
43 countries* 
43 hospitals, 1 
country(UK) 
 43 hospitals, 1 
country(UK) 
 
Mortality % 4.8% 3.9% 2.6% 2.5% 
*Data from UK were included in both ES and ES2. 
Table S2. Performance of updated CPMs on the validation dataset.  
 Discrimination  Cox recalibration  
Strategy AUC (95% CI)  Intercept (SE) Slope (SE) 
     
Original 
EURO1 (ES) 
0.8155 (0.8027-0.8283)  -1.13477(0.034525)* 0.96628(0.014281)* 
I 0.8155 (0.8027-0.8283)  -0.13324(0.034525)* 0.98182(0.010569) 
II 0.8155 (0.8027-0.8283)  -0.12329(0.034204)* 0.99448(0.010579) 
III 0.8268(0.8143-0.8393)  -0.10687(0.034273)* 0.99667(0.010747) 
IV ( =0.99) 0.8265 (0.814-0.839)  -0.13333(0.034228)* 0.99895(0.010815) 
     
Original 
EURO2 (ES2) 
0.8245 (0.8118-0.8372)  -0.27264(0.034068)* 1.00694(0.011196) 
I 0.8245 (0.8118-0.8372)  -0.14656(0.034068)* 1.00644(0.010787) 
II 0.8245 (0.8118-0.8372)  -0.16590(0.034533)* 0.98860(0.010804) 
III 0.8319 (0.8194-0.8444)  -0.17494(0.034520)* 0.99037(0.011078) 
IV(=0.99) 0.8318 (0.8193-0.8443)  -0.19441(0.034472)* 0.99276 (0.011134) 
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Meta-model     
V 0.8247 (0.8121-0.8373)  -0.14833(0.034225)* 1.00010  (0.010782) 
VI 0.8261 (0.8135-0.8387)  -0.15935(0.034520)* 0.98983 (0.010803) 
Values of intercept and slope in bold are significantly different from 0 or 1 respectively, 
using a p-value cutoff of 0.05.
